Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial (Nature Medicine, (2022), 28, 12, (2504-2511), 10.1038/s41591-022-02102-9)

  • Orly Vardeny
  • , James C. Fang
  • , Akshay S. Desai
  • , Pardeep S. Jhund
  • , Brian Claggett
  • , Muthiah Vaduganathan
  • , Rudolf A. de Boer
  • , Adrian F. Hernandez
  • , Carolyn S.P. Lam
  • , Silvio E. Inzucchi
  • , Felipe A. Martinez
  • , Mikhail N. Kosiborod
  • , David DeMets
  • , Eileen O’Meara
  • , Shelley Zieroth
  • , Josep Comin-Colet
  • , Jaroslaw Drozdz
  • , Chern En Chiang
  • , Masafumi Kitakaze
  • , Magnus Petersson
    • Daniel Lindholm, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial (Nature Medicine, (2022), 28, 12, (2504-2511), 10.1038/s41591-022-02102-9)'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Psychology